Led by Prof. Adam Mossoff and C-IP2 Senior Fellow and Senior Scholar Prof. Jonathan M. Barnett, twenty-five law professors, economists, and former United States Government officials—including C-IP2 Advisory Board members the Honorable Andrei Iancu, the Honorable David J. Read more
Blog
GRAMMY-winning Composer and Mason Artist-in-Residence Maria Schneider Led Events Across Mason Campuses
The following post comes from Laura Mertens and is cross-posted here from Mason’s Center for the Arts website with permission.
Known for fearless musical exploration and beautifully blurring lines between genres, composer Maria Schneider has earned seven GRAMMY Awards across the realms of jazz, classical, and even her work with David Bowie. Read more
Note to C-IP2 Community on Scalia Law Professor Tweet in Dobbs Opinion Leak Debates
Last week a Scalia Law School faculty member tweeted a breathtakingly offensive remark about a sitting Supreme Court justice from his personal account in the context of the leaked Dobbs opinion. It has come to light that this same professor has tweeted similarly disparaging comments regarding other groups that have endured longstanding discrimination. Read more
C-IP2 2022 Spring Progress Report (December 2021-February 2022)
Greetings from C-IP2 Faculty Director Sean O’Connor
As we move further into spring of 2022, we are simultaneously emerging––gradually and hopefully––from the global health crisis of these past two years. In-person gatherings and events are steadily resuming in the Washington, D.C., Read more
Paradise Rejected: A Conversation about AI and Authorship with Dr. Ryan Abbott
This post comes from Sandra Aistars, Clinical Professor and Director of the Arts & Entertainment Advocacy Clinic at George Mason University, Antonin Scalia Law School, and Senior Fellow for Copyright Research and Policy & Senior Scholar at C-IP2.
On March 17, 2022, I had the pleasure to discuss Artificial Intelligence and Authorship with Dr. Read more
Recap of the Supreme Court’s Unicolors, Inc. v. H&M Hennes & Mauritz, L.P.
The following post comes from Sabren H. Wahdan, a 3L at Scalia Law and a Research Assistant at C-IP2.
In one of his final majority opinions before announcing his retirement, Justice Steven Breyer penned a nuanced ruling that carefully threads the policy needle on copyright registration issues. Read more
Photography, Portrait Subjects, and Copyright Law
By Molly Stech*
*The blog post below and the law review article it links to are the individual thoughts and views of the author and should not be attributed to any entity with which she is currently or has been affiliated. Read more
C-IP2 2021 Winter Progress Report (September-November 2021)
Greetings from C-IP2 Faculty Director Sean O’Connor
Warmest greetings for this holiday season. While 2021 has continued to be challenging, we are thankful that our community has stayed strong and thrived, nonetheless. We hope that if the pandemic has directly affected you or your loved ones, you are finding your way back to peace and health. Read more
C-IP2 2021 Fall Progress Report (June-August 2021)
Greetings from C-IP2 Faculty Director Sean O’Connor
Now that fall has officially begun, C-IP2 is wrapping up the summer with our Fall Progress Report for 2021 covering activities June through August. This is also our first progress report under our new name, since we rebranded on July 1 as the Center for Intellectual Property x Innovation Policy (C-IP2, also: C-IP2), formerly the Center for the Protection of Intellectual Property (CPIP). Read more
Reply and Response to C-IP2’s March 4, 2021, Blogpost on UC Hastings’ Evergreen Drug Patent Search Database
C-IP2’s original post on the UC Hastings’ Evergreen Drug Patent Search Database can be read here.
Reply to Blog Post on UC Hastings’ Evergreen Drug Patent Search Database
Robin Feldman
Arthur J. Goldberg Distinguished Professor of Law
Albert Abramson ’54 Distinguished Professor of Law Chair
Director of the Center for Innovation at University of California Hastings
We would like to thank the author of the blog post for taking the time to look at our work for the Evergreen Drug Patent Database. Read more